Researchers at Washington University School of Medicine in St. Louis have found that multidrug-resistant bacteria and bacterial spores can be killed by ultrashort-pulse lasers. The findings could lead to new ways to sterilize wounds and blood products without damaging human cells.
The Icahn School of Medicine at Mount Sinai is among the 22 recipient institutions of the largest U.S. collaborative funding effort for equity in biomedicine, a $12.1 million effort made possible by the Doris Duke Charitable Foundation.
The Commonwealth of Pennsylvania has granted The Wistar Institute $4 million to fund COVID-19 research focused on understanding the impact of COVID-19 on certain at-risk populations and supporting the commonwealth’s preparation and emergency response planning for future pandemics.
A new therapeutic approach prevents the growth of metastatic tumors in mice by forcing cancer cells into a dormant state in which they are unable to proliferate. The study, published November 23 in the Journal of Experimental Medicine (JEM), could lead to new treatments that prevent the recurrence or spread of various cancer types, including breast cancer and head and neck squamous cell carcinoma (HNSCC).
In May 2021, the Centers for Disease Control officially recognized that SARS-CoV-2 is airborne. Now UC San Diego Professor Rommie Amaro has modeled the delta virus inside an aerosol for the first time.
Clonal hematopoiesis, a condition in which mutations associated with blood cancers are found in the blood of healthy people, is common with aging. When looking for appropriate stem cell/bone marrow donors, clinicians tend to stay away from older donors with clonal hematopoiesis (CH) because of concerns about passing potentially premalignant stem cells to the recipient.
The Harold C. Simmons Comprehensive Cancer Center has been awarded grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to increase minority participation in clinical trials, expand lung cancer screening, develop brain tumor drugs, and advance innovations in drug discovery and technology.
About 7.5 million Americans suffer from psoriasis, an autoimmune disease that shows up as patches of red, inflamed skin and painful, scaly rashes. Although there are effective treatments for psoriasis, not everyone responds to these therapies—and for many, the relief is temporary.
The Woods Hole Oceanographic Institution (WHOI) has received $750,000 in funding from the U.S. Department of Energy (DOE) to develop next‐generation autonomous robotic technology for environmental monitoring of marine organisms and the seafloor at potential wind energy development areas on the U.S. West Coast.
People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer's COVID-19 vaccine, according to a study from Washington University School of Medicine in St. Louis. A third vaccine dose drove antibody levels back up, indicating that this additional dose may provide protection as the virus's delta variant continues to spread.
Houston Methodist has received a $25 million philanthropic gift from Dr. Mary and Ron Neal to expand the hospital system’s cancer center.
A new study from the University of Michigan Health Rogel Cancer Center finds circulating tumor DNA, or ctDNA, levels can predict as early as two weeks after starting treatment which patients are likely to have good outcomes. At the same time, specialized MRI and PET scans two weeks after starting chemoradiation also correlated with outcomes.
New research shows how genetic variations linked to severe cases of COVID-19 affect our immune cells. The study is one of the first in-depth look at the connections between COVID-19 severity and gene expression in many types of immune cells. This work could guide the development of new COVID-19 therapies to boost immune cell function.
Physicians at Washington University School of Medicine in St. Louis and Massachusetts General Hospital/Harvard Medical School in Boston have received a seven-year, $22 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to help lead a multicenter clinical trial evaluating whether a novel immunosuppressant can reduce the risk of organ rejection after a lung transplant.
An Indiana University cancer researcher is leading an $11.4 million grant from the National Cancer Institute in which he and others across the country will work on identifying new treatments for tumors that develop in children, adolescents and adults with a common genetic condition.
A new UC Davis MIND Institute study suggests that parent-led language testing delivered via telehealth is effective for children with autism. The format was tested in both English and Spanish-speaking families and may provide a new way to measure the efficacy of treatments.
The "Expanded Interprofessional Medication-Assisted Treatment Training Program" is a three-year grant totaling about $450,000 from the Substance Abuse and Mental Health Service Administration (SAMHSA), a branch of the U.S. Department of Health and Human Services.
The American Association of Critical-Care Nurses announces the recipients of its three 2021 AACN Impact Research Grants, with up to $50,000 in funding each. Since launching the grant program in 2011, AACN has awarded more than $1 million and 27 Impact Research Grants.
It’s sometimes possible to link public face images with public genomic data, but the success rates are well below what prior research papers suggest in idealized settings, new research from Yevgeniy Vorobeychik's lab shows.
Both rare and commonly observed differences in the DNA letters strung along a person’s chromosomes can explain about a third of the risk for being diagnosed with obsessive-compulsive disorder (OCD), according to a new study led by scientists at the Icahn School of Medicine at Mount Sinai.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
